ISOVUE-M is a Intrathecal Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Bipso Gmbh. The primary component is Iopamidol.
| Product ID | 76381-411_d038c2e6-5270-c2ac-9900-523456ef927c |
| NDC | 76381-411 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ISOVUE-M |
| Generic Name | Iopamidol |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRATHECAL |
| Marketing Start Date | 1985-12-31 |
| Marketing Category | NDA / NDA |
| Application Number | NDA018735 |
| Labeler Name | BIPSO GmbH |
| Substance Name | IOPAMIDOL |
| Active Ingredient Strength | 408 mg/mL |
| Pharm Classes | Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 1985-12-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Ingredient | Strength |
|---|---|
| IOPAMIDOL | 408 mg/mL |
| SPL SET ID: | 1215a15d-b06b-4d34-b83f-7203a526c52f |
| Manufacturer | |
| UNII |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 76381-412 | ISOVUE-M | ISOVUE-M |
| 76381-411 | ISOVUE-M | ISOVUE-M |
| 0270-1411 | ISOVUE-M | ISOVUE-M |
| 0270-1412 | ISOVUE-M | ISOVUE-M |
| 0270-1314 | ISOVUE | IOPAMIDOL |
| 0270-1315 | ISOVUE | IOPAMIDOL |
| 0270-1316 | ISOVUE | IOPAMIDOL |
| 0270-1317 | ISOVUE | IOPAMIDOL |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ISOVUE-M 73468617 1312031 Live/Registered |
E. R. Squibb & Sons, Inc. 1984-03-05 |